These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 29093471)

  • 1. Antithrombotic properties of JJ1, a potent and novel thrombin inhibitor.
    Lee W; Lee S; Choi J; Park JH; Kim KM; Jee JG; Bae JS
    Sci Rep; 2017 Nov; 7(1):14862. PubMed ID: 29093471
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antithrombotic and antiplatelet activities of small-molecule alkaloids from Scolopendra subspinipes mutilans.
    Lee W; Lee J; Kulkarni R; Kim MA; Hwang JS; Na M; Bae JS
    Sci Rep; 2016 Feb; 6():21956. PubMed ID: 26905699
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antithrombotic properties of RWJ-50353, a potent and novel thrombin inhibitor.
    Giardino EC; Costanzo MJ; Kauffman JA; Li QS; Maryanoff BE; Andrade-Gordon P
    Thromb Res; 2000 Apr; 98(1):83-93. PubMed ID: 10706936
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro and in vivo properties of bicyclic lactam inhibitors: a novel class of low molecular weight peptidomimetic thrombin inhibitors.
    Leblond L; Grouix B; Boudreau C; Yang Q; Siddiqui MA; Winocour PD
    Thromb Res; 2000 Nov; 100(3):195-209. PubMed ID: 11108907
    [TBL] [Abstract][Full Text] [Related]  

  • 5. BCH-2763, a novel potent parenteral thrombin inhibitor, is an effective antithrombotic agent in rodent models of arterial and venous thrombosis--comparisons with heparin, r-hirudin, hirulog, inogatran and argatroban.
    Finkle CD; St Pierre A; Leblond L; Deschenes I; DiMaio J; Winocour PD
    Thromb Haemost; 1998 Feb; 79(2):431-8. PubMed ID: 9493603
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Discovery of novel, potent, isosteviol-based antithrombotic agents.
    Chen P; Zhang D; Li M; Wu Q; Lam YPY; Guo Y; Chen C; Bai N; Malhotra S; Li W; O'Connor PB; Fu H
    Eur J Med Chem; 2019 Dec; 183():111722. PubMed ID: 31563807
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antithrombotic activities of aspalathin and nothofagin via inhibiting platelet aggregation and FIIa/FXa.
    Ku SK; Lee W; Kang M; Bae JS
    Arch Pharm Res; 2015 Jun; 38(6):1080-9. PubMed ID: 25325928
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In-depth study of tripeptide-based alpha-ketoheterocycles as inhibitors of thrombin. Effective utilization of the S1' subsite and its implications to structure-based drug design.
    Costanzo MJ; Almond HR; Hecker LR; Schott MR; Yabut SC; Zhang HC; Andrade-Gordon P; Corcoran TW; Giardino EC; Kauffman JA; Lewis JM; de Garavilla L; Haertlein BJ; Maryanoff BE
    J Med Chem; 2005 Mar; 48(6):1984-2008. PubMed ID: 15771442
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antithrombotic and hemostatic capacity of factor Xa versus thrombin inhibitors in models of venous and arteriovenous thrombosis.
    Sinha U; Ku P; Malinowski J; Zhu BY; Scarborough RM; Marlowe CK; Wong PW; Lin PH; Hollenbach SJ
    Eur J Pharmacol; 2000 Apr; 395(1):51-9. PubMed ID: 10781674
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and in Vitro and in Vivo Anticoagulant and Antiplatelet Activities of Amidino- and Non-Amidinobenzamides.
    Lee SH; Lee W; Bae JS; Ma E
    Molecules; 2016 May; 21(5):. PubMed ID: 27213328
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-thrombotic Effects Mediated by a Novel Dual-Target Peptide Inhibiting Both Platelet Aggregation and Thrombin Activity without Causing Bleeding.
    Yu J; Wang T; Zhang X; Chen Q; Hu Y; Liang Q; Shi Y; Wang Y; Zhang Y; Yu M; Zhao B
    Thromb Haemost; 2024 Feb; 124(2):108-121. PubMed ID: 37657484
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antithrombotic efficacy of thrombin inhibitor L-374,087: intravenous activity in a primate model of venous thrombus extension and oral activity in a canine model of primary venous and coronary artery thrombosis.
    Cook JJ; Gardell SJ; Holahan MA; Sitko GR; Stump GL; Wallace AA; Gilberto DB; Hare TR; Krueger JA; Dyer DL; Sanderson PE; Vacca JP; Shafer JA; Lynch JJ
    J Pharmacol Exp Ther; 1999 Apr; 289(1):503-10. PubMed ID: 10087043
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antithrombotic activities of pellitorine in vitro and in vivo.
    Ku SK; Lee IC; Kim JA; Bae JS
    Fitoterapia; 2013 Dec; 91():1-8. PubMed ID: 23973654
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anticoagulant and antithrombotic action of the synthetic thrombin inhibitor D-phenylalanyl-L-prolyl-L-arginine nitrile.
    Kaiser B; Richter M; Hauptmann J; Markwardt F
    Pharmazie; 1991 Feb; 46(2):128-31. PubMed ID: 1852761
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Profiling the structural determinants for the selectivity of representative factor-Xa and thrombin inhibitors using combined ligand-based and structure-based approaches.
    Bhunia SS; Roy KK; Saxena AK
    J Chem Inf Model; 2011 Aug; 51(8):1966-85. PubMed ID: 21761917
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Selection of S18326 as a new potent and selective boronic acid direct thrombin inhibitor.
    Rupin A; Mennecier P; Lila C; de Nanteuil G; Verbeuren TJ
    Thromb Haemost; 1997 Oct; 78(4):1221-7. PubMed ID: 9364988
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibitory effects of J78, a newly synthesized 1,4-naphthoquinone derivative, on experimental thrombosis and platelet aggregation.
    Jin YR; Ryu CK; Moon CK; Cho MR; Yun YP
    Pharmacology; 2004 Apr; 70(4):195-200. PubMed ID: 15001820
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antithrombotic activity of LB30057, a newly synthesized direct thrombin inhibitor.
    Kang KT; Jung BI; Bae ON; Lee MY; Chung SM; Lee JY; Lee SK; Kim IC; Chung JH
    Thromb Haemost; 2003 Jan; 89(1):104-11. PubMed ID: 12540960
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of AR-H067637, the active metabolite of the new direct thrombin inhibitor AZD0837, in models of venous and arterial thrombosis and bleeding in anaesthetised rats.
    Pehrsson S; Johansson K; Kjaer M; Elg M
    Thromb Haemost; 2010 Dec; 104(6):1242-9. PubMed ID: 20806126
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antithrombotic drugs: part I.
    Gallus AS; Hirsh J
    Drugs; 1976; 12(1):41-68. PubMed ID: 789043
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.